#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	1	0	27	424	AAC_2___Ic	546	546	100.0	AAC_2___Ic.l6.c30.ctg.1	1226	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b"AAC(2')-Ic is a chromosomal-encoded aminoglycoside acetyltransferase in M. tuberculosis and Mycobacterium tuberculosis variant bovis.";AAC(2')-Ic
Erm_37_.3000392.AL123456.1.2231679_2232219.582	Erm_37_.3000392.AL123456.1.2231679_2232219.582	1	0	27	352	Erm_37_	540	540	100.0	Erm_37_.l15.c4.ctg.1	1392	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'Erm(37) is found in Mycobacterium species and confers the MLSb phenotype. In addition to methylation of A2058 this Erm methylates adjacent adenosines (A2057 and A2059) as well.';Erm(37)
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	A2526G	SNP	2526	2526	A	33	33	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	G2536A	SNP	2536	2536	G	43	43	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	C2593T	SNP	2593	2593	C	100	100	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	A2895G	SNP	2895	2895	A	402	402	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	T2896C	SNP	2896	2896	T	403	403	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	T2906C	SNP	2906	2906	T	413	413	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	A2909G	SNP	2909	2909	A	416	416	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	A2915G	SNP	2915	2915	A	422	422	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	G2920C	SNP	2920	2920	G	427	427	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	A2940T	SNP	2940	2940	A	447	447	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	T3002C	SNP	3002	3002	T	509	509	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	A3005G	SNP	3005	3005	A	512	512	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	A3007T	SNP	3007	3007	A	514	514	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	C3028A	SNP	3028	3028	C	535	535	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	G3038A	SNP	3038	3038	G	545	545	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	T3045C	SNP	3045	3045	T	552	552	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	C3062T	SNP	3062	3062	C	569	569	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	A3067G	SNP	3067	3067	A	574	574	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	C3071T	SNP	3071	3071	C	578	578	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	610	96.07	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	670	0.0	0	.	n	.	0	A3083G	SNP	3083	3083	A	590	590	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	C470T	SNP	470	470	C	22	22	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	A514G	SNP	514	514	A	66	66	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	C522.	DEL	522	522	C	73	73	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	C524A	SNP	524	524	C	75	75	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	A526T	SNP	526	526	A	77	77	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	T542G	SNP	542	542	T	93	93	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	C609T	SNP	609	609	C	160	160	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	T627C	SNP	627	627	T	178	178	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	.633A	INS	633	633	T	185	185	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	.636T	INS	636	636	G	189	189	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	G657T	SNP	657	657	G	210	210	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	G663T	SNP	663	663	G	216	216	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	A678G	SNP	678	678	A	231	231	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	C681T	SNP	681	681	C	234	234	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	C696A	SNP	696	696	C	249	249	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	C701T	SNP	701	701	C	254	254	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	G704T	SNP	704	704	G	257	257	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	C712T	SNP	712	712	C	265	265	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	C715G	SNP	715	715	C	268	268	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	273	90.91	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	289	0.0	0	.	n	.	0	G720C	SNP	720	720	G	273	273	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	183	97.81	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.3	323	0.0	0	.	n	.	0	T8C	SNP	8	8	T	148	148	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	183	97.81	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.3	323	0.0	0	.	n	.	0	A96G	SNP	96	96	A	236	236	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	183	97.81	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.3	323	0.0	0	.	n	.	0	T98G	SNP	98	98	T	238	238	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	56	Mycobacterium_intracellulare_23S_1	3103	183	97.81	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.3	323	0.0	0	.	n	.	0	T146C	SNP	146	146	T	286	286	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	186	98.92	Mycobacterium_kansasii_23S.l15.c4.ctg.1	323	0.0	0	.	n	.	0	A74T	SNP	74	74	A	211	211	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	186	98.92	Mycobacterium_kansasii_23S.l15.c4.ctg.1	323	0.0	0	.	n	.	0	T149C	SNP	149	149	T	286	286	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	T2524G	SNP	2524	2524	T	31	31	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	G2536A	SNP	2536	2536	G	43	43	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	C2563T	SNP	2563	2563	C	70	70	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	C2593T	SNP	2593	2593	C	100	100	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	T2609C	SNP	2609	2609	T	116	116	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	T2611C	SNP	2611	2611	T	118	118	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	G2841A	SNP	2841	2841	G	348	348	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	A2892G	SNP	2892	2892	A	399	399	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	A2909G	SNP	2909	2909	A	416	416	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	T2931C	SNP	2931	2931	T	438	438	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	A2940T	SNP	2940	2940	A	447	447	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	C2991T	SNP	2991	2991	C	498	498	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	G3038A	SNP	3038	3038	G	545	545	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	C3044T	SNP	3044	3044	C	551	551	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	A3067G	SNP	3067	3067	A	574	574	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	A3071T	SNP	3071	3071	A	578	578	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	A3083G	SNP	3083	3083	A	590	590	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	52	Mycobacterium_kansasii_23S	3118	616	96.92	Mycobacterium_kansasii_23S.l15.c4.ctg.2	670	0.0	0	.	n	.	0	C3103.	DEL	3103	3103	C	609	609	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	512	160	Mycobacterium_tuberculosis_16S_4	1537	643	100.0	Mycobacterium_tuberculosis_16S_4.l15.c17.ctg.1	796	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	512	160	Mycobacterium_tuberculosis_16S_4	1537	337	98.81	Mycobacterium_tuberculosis_16S_4.l15.c17.ctg.2	509	0.0	0	.	n	.	0	C1259T	SNP	1259	1259	C	59	59	T	ND	ND	ND	.	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	512	160	Mycobacterium_tuberculosis_16S_4	1537	337	98.81	Mycobacterium_tuberculosis_16S_4.l15.c17.ctg.2	509	0.0	0	.	n	.	0	A1266T	SNP	1266	1266	A	66	66	T	ND	ND	ND	.	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	512	160	Mycobacterium_tuberculosis_16S_4	1537	337	98.81	Mycobacterium_tuberculosis_16S_4.l15.c17.ctg.2	509	0.0	0	.	n	.	0	A1278T	SNP	1278	1278	A	78	78	T	ND	ND	ND	.	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	512	160	Mycobacterium_tuberculosis_16S_4	1537	337	98.81	Mycobacterium_tuberculosis_16S_4.l15.c17.ctg.2	509	0.0	1	SNP	n	A1401G	0	.	.	1401	1401	A	201	201	A	ND	ND	ND	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921:0:0:A1401G:.:b"Point mutations in the 3' domain of 16S rRNA of Mycobacterium tuberculosis can confer resistance to capreomycin."	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	27	794	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	100.0	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.1	2169	0.0	1	SNP	p	V219A	0	.	.	655	657	GTC	1063	1065	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:V219A:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	27	794	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	100.0	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.1	2169	0.0	1	SNP	p	S292L	0	.	.	874	876	TCG	1282	1284	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:S292L:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	768	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c17.ctg.1	2198	0.0	1	SNP	p	R13C	0	.	.	37	39	CGT	526	528	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R13C:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	768	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c17.ctg.1	2198	0.0	1	SNP	p	V18A	0	.	.	52	54	GTG	541	543	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:V18A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	768	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c17.ctg.1	2198	0.0	1	SNP	p	L50V	0	.	.	148	150	CTG	637	639	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:L50V:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	768	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c17.ctg.1	2198	0.0	1	SNP	p	T110A	0	.	.	328	330	ACC	817	819	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:T110A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	768	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c17.ctg.1	2198	0.0	1	SNP	p	R268H	0	.	.	802	804	CGC	1291	1293	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R268H:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	768	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c17.ctg.1	2198	0.0	1	SNP	p	A300P	0	.	.	898	900	GCC	1387	1389	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:A300P:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	768	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c17.ctg.1	2198	0.0	1	SNP	p	G313R	0	.	.	937	939	GGG	1426	1428	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G313R:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	768	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l6.c17.ctg.1	2198	0.0	1	SNP	p	G339A	0	.	.	1015	1017	GGG	1504	1506	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G339A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	.47T	INS	47	47	G	241	241	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	C49T	SNP	49	49	C	243	243	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	G57A	SNP	57	57	G	252	252	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	C108T	SNP	108	108	C	303	303	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	T109C	SNP	109	109	T	304	304	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	A153G	SNP	153	153	A	348	348	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	C156A	SNP	156	156	C	351	351	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	T158G	SNP	158	158	T	353	353	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	G165T	SNP	165	165	G	360	360	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	A166T	SNP	166	166	A	361	361	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	C173G	SNP	173	173	C	368	368	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	.176GC	INS	176	176	A	372	372	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	T182A	SNP	182	182	T	379	379	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	A227G	SNP	227	227	A	424	424	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	T229C	SNP	229	229	T	426	426	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	C234T	SNP	234	234	C	431	431	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	A271T	SNP	271	271	A	468	468	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	A372G	SNP	372	372	A	569	569	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	T408C	SNP	408	408	T	605	605	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	G411C	SNP	411	411	G	608	608	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	.420GGTTCTCTC	INS	420	420	G	621	621	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	A422G	SNP	422	422	A	631	631	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	G424T	SNP	424	424	G	633	633	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	C434G	SNP	434	434	C	643	643	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	C437G	SNP	437	437	C	646	646	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	G446C	SNP	446	446	G	655	655	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	C489G	SNP	489	489	C	698	698	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	A555T	SNP	555	555	A	764	764	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	A561G	SNP	561	561	A	770	770	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	102	Mycobacteroides_chelonae_16S_4	1441	597	91.52	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	806	0.0	0	.	n	.	0	G573A	SNP	573	573	G	782	782	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	C2600T	SNP	2600	2600	C	9	9	T	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	G2604A	SNP	2604	2604	G	13	13	A	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	G2616T	SNP	2616	2616	G	25	25	T	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	C2625A	SNP	2625	2625	C	34	34	A	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	G2643A	SNP	2643	2643	G	52	52	A	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	G2644C	SNP	2644	2644	G	53	53	C	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	C2661T	SNP	2661	2661	C	70	70	T	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	C2778A	SNP	2778	2778	C	187	187	A	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	T2815C	SNP	2815	2815	T	224	224	C	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	C2855T	SNP	2855	2855	C	264	264	T	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	T2864C	SNP	2864	2864	T	273	273	C	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	T2866C	SNP	2866	2866	T	275	275	C	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	G2874A	SNP	2874	2874	G	283	283	A	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	G2877A	SNP	2877	2877	G	286	286	A	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	T2878A	SNP	2878	2878	T	287	287	A	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	A2885G	SNP	2885	2885	A	294	294	G	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	G2889C	SNP	2889	2889	G	298	298	C	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	G2934A	SNP	2934	2934	G	343	343	A	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	T2945C	SNP	2945	2945	T	354	354	C	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	A2950G	SNP	2950	2950	A	359	359	G	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	G2957C	SNP	2957	2957	G	366	366	C	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	T2963A	SNP	2963	2963	T	372	372	A	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	G2965A	SNP	2965	2965	G	374	374	A	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	T2968C	SNP	2968	2968	T	377	377	C	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	Streptomyces_ambofaciens_23S.3004171.NZ_CP012949.1.4334992_4338141.4163	0	0	528	12	Streptomyces_ambofaciens_23S	3149	397	91.44	Streptomyces_ambofaciens_23S.l15.c30.ctg.1	397	0.0	0	.	n	.	0	G2979A	SNP	2979	2979	G	388	388	A	ND	ND	ND	.	Streptomyces ambofaciens 23S rRNA with mutation conferring resistance to macrolide antibiotics
blaC.3007182.AL123456.3.2325885_2326809.8481	blaC.3007182.AL123456.3.2325885_2326809.8481	1	0	27	570	blaC	924	924	100.0	blaC.l15.c4.ctg.1	1503	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	blaC;b'blaC is a broad-spectrum class A beta-lactamase coded in the chromosome of Mycobacterium tuberculosis. It has been shown to hydrolyze a large number of beta-lactam antibiotics and is a major obstacle in the treatment of tuberculosis with such drugs.'
efpA.3003955.AL123456.3.3153038_3154631.5259	efpA.3003955.AL123456.3.3153038_3154631.5259	1	0	27	978	efpA	1593	1593	100.0	efpA.l15.c4.ctg.1	2367	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'efpA is an MFS transporter found in Mycobacterium tuberculosis.';efpA
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	1654	embA	3285	3285	99.97	embA.l15.c4.ctg.1	4051	0.0	0	.	p	.	0	P838L	NONSYN	2512	2514	CCG	2802	2804	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	1654	embA	3285	3285	99.97	embA.l15.c4.ctg.1	4051	0.0	1	SNP	p	D4N	0	.	.	10	12	GAC	300	302	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D4N:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	1654	embA	3285	3285	99.97	embA.l15.c4.ctg.1	4051	0.0	1	SNP	p	G5S	0	.	.	13	15	GGT	303	305	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G5S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	1654	embA	3285	3285	99.97	embA.l15.c4.ctg.1	4051	0.0	1	SNP	p	A201T	0	.	.	601	603	GCG	891	893	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A201T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	1654	embA	3285	3285	99.97	embA.l15.c4.ctg.1	4051	0.0	1	SNP	p	G321S	0	.	.	961	963	GGC	1251	1253	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G321S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	1654	embA	3285	3285	99.97	embA.l15.c4.ctg.1	4051	0.0	1	SNP	p	G350D	0	.	.	1048	1050	GGC	1338	1340	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G350D:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	1654	embA	3285	3285	99.97	embA.l15.c4.ctg.1	4051	0.0	1	SNP	p	A462V	0	.	.	1384	1386	GCG	1674	1676	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A462V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	1654	embA	3285	3285	99.97	embA.l15.c4.ctg.1	4051	0.0	1	SNP	p	D833A	0	.	.	2497	2499	GAC	2787	2789	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D833A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	539	1654	embA	3285	3285	99.97	embA.l15.c4.ctg.1	4051	0.0	1	SNP	p	P913S	0	.	.	2737	2739	CCG	3027	3029	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:P913S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	L239P	0	.	.	715	717	CTG	1031	1033	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L239P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	D240H	0	.	.	718	720	GAC	1034	1036	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D240H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	S297A	0	.	.	889	891	TCG	1205	1207	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S297A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	D299E	0	.	.	895	897	GAC	1211	1213	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D299E:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	M306T	0	.	.	916	918	ATG	1232	1234	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306T:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	M306V	0	.	.	916	918	ATG	1232	1234	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	M306I	0	.	.	916	918	ATG	1232	1234	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306I:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	M306L	0	.	.	916	918	ATG	1232	1234	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306L:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	D311H	0	.	.	931	933	GAC	1247	1249	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D311H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	Y319N	0	.	.	955	957	TAT	1271	1273	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	Y319C	0	.	.	955	957	TAT	1271	1273	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	D328Y	0	.	.	982	984	GAT	1298	1300	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328Y:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	D328G	0	.	.	982	984	GAT	1298	1300	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	F330V	0	.	.	988	990	TTC	1304	1306	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:F330V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	Y333C	0	.	.	997	999	TAT	1313	1315	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y333C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	Y334H	0	.	.	1000	1002	TAC	1316	1318	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y334H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	A356V	0	.	.	1066	1068	GCC	1382	1384	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A356V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	A357S	0	.	.	1069	1071	GCC	1385	1387	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A357S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	E368A	0	.	.	1102	1104	GAG	1418	1420	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E368A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	P375A	0	.	.	1123	1125	CCG	1439	1441	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P375A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	E378A	0	.	.	1132	1134	GAG	1448	1450	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E378A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	S380R	0	.	.	1138	1140	AGC	1454	1456	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S380R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	P397Q	0	.	.	1189	1191	CCG	1505	1507	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P397Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	N399H	0	.	.	1195	1197	AAC	1511	1513	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:N399H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	G406D	0	.	.	1216	1218	GGC	1532	1534	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	G406C	0	.	.	1216	1218	GGC	1532	1534	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	G406S	0	.	.	1216	1218	GGC	1532	1534	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	G406A	0	.	.	1216	1218	GGC	1532	1534	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	L413P	0	.	.	1237	1239	CTG	1553	1555	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L413P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	P446H	0	.	.	1336	1338	CCC	1652	1654	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P446H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	R460C	0	.	.	1378	1380	CGC	1694	1696	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R460C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	I465D	0	.	.	1393	1395	ATC	1709	1711	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:I465D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	R469P	0	.	.	1405	1407	CGT	1721	1723	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R469P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	R471P	0	.	.	1411	1413	CGC	1727	1729	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R471P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	Q497K	0	.	.	1489	1491	CAG	1805	1807	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497K:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	Q497R	0	.	.	1489	1491	CAG	1805	1807	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	E504Q	0	.	.	1510	1512	GAA	1826	1828	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E504Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	R507G	0	.	.	1519	1521	AGG	1835	1837	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R507G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	G745D	0	.	.	2233	2235	GGC	2549	2551	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G745D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	D959A	0	.	.	2875	2877	GAC	3191	3193	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D959A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	M1000R	0	.	.	2998	3000	ATG	3314	3316	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M1000R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1942	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3969	0.0	1	SNP	p	D1024N	0	.	.	3070	3072	GAC	3386	3388	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D1024N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	R738Q	1	R738Q	NONSYN	2212	2214	CGG	2554	2556	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R738Q:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	A247P	0	.	.	739	741	GCG	1081	1083	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A247P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	L251R	0	.	.	751	753	CTG	1093	1095	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L251R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	A254G	0	.	.	760	762	GCC	1102	1104	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A254G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	T270I	0	.	.	808	810	ACC	1150	1152	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:T270I:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	H285Y	0	.	.	853	855	CAT	1195	1197	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:H285Y:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	V287F	0	.	.	859	861	GTC	1201	1203	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V287F:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	G288W	0	.	.	862	864	GGG	1204	1206	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288W:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	G288V	0	.	.	862	864	GGG	1204	1206	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288V:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	Y296S	0	.	.	886	888	TAC	1228	1230	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	Y296H	0	.	.	886	888	TAC	1228	1230	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296H:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	I297T	0	.	.	889	891	ATC	1231	1233	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	I297L	0	.	.	889	891	ATC	1231	1233	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	M300R	0	.	.	898	900	ATG	1240	1242	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M300R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	R302G	0	.	.	904	906	CGG	1246	1248	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R302G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	V303G	0	.	.	907	909	GTG	1249	1251	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V303G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	A307T	0	.	.	919	921	GCG	1261	1263	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A307T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	G308D	0	.	.	922	924	GGC	1264	1266	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G308D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	Y309N	0	.	.	925	927	TAT	1267	1269	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y309N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	M310K	0	.	.	928	930	ATG	1270	1272	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M310K:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	G325S	0	.	.	973	975	GGC	1315	1317	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G325S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	W326R	0	.	.	976	978	TGG	1318	1320	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:W326R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	Y327N	0	.	.	979	981	TAC	1321	1323	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y327N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	N394D	0	.	.	1180	1182	AAC	1522	1524	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:N394D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	P398S	0	.	.	1192	1194	CCC	1534	1536	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:P398S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	Q491R	0	.	.	1471	1473	CAG	1813	1815	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Q491R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	L502P	0	.	.	1504	1506	CTC	1846	1848	CTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L502P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1766	embC	3285	3285	99.94	embC.l6.c17.ctg.1	3798	0.0	1	SNP	p	V981L	0	.	.	2941	2943	GTG	3283	3285	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V981L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	27	814	embR	1167	1167	100.0	embR.l15.c4.ctg.1	1822	0.0	1	SNP	p	C110Y	0	.	.	328	330	TGC	630	632	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:C110Y:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	27	814	embR	1167	1167	100.0	embR.l15.c4.ctg.1	1822	0.0	1	SNP	p	Q379R	0	.	.	1135	1137	CAG	1437	1439	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:Q379R:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	P28S	0	.	.	82	84	CCG	398	400	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:P28S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	L35R	0	.	.	103	105	CTG	419	421	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L35R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	G42D	0	.	.	124	126	GGC	440	442	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:G42D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	D56Y	0	.	.	166	168	GAC	482	484	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D56Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	D58G	0	.	.	172	174	GAC	488	490	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D58G:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	W69C	0	.	.	205	207	TGG	521	523	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:W69C:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	H102P	0	.	.	304	306	CAC	620	622	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:H102P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	Y141N	0	.	.	421	423	TAC	737	739	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Y141N:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	V179F	0	.	.	535	537	GTC	851	853	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:V179F:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	T186P	0	.	.	556	558	ACG	872	874	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T186P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	T189R	0	.	.	565	567	ACG	881	883	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T189R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	Q246P	0	.	.	736	738	CAG	1052	1054	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q246P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	Q254P	0	.	.	760	762	CAG	1076	1078	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q254P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	L267V	0	.	.	799	801	CTG	1115	1117	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L267V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	S329P	0	.	.	985	987	TCA	1301	1303	TCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:S329P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	A341V	0	.	.	1021	1023	GCA	1337	1339	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A341V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	N345K	0	.	.	1033	1035	AAC	1349	1351	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:N345K:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	A352E	0	.	.	1054	1056	GCG	1370	1372	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A352E:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	M372R	0	.	.	1114	1116	ATG	1430	1432	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:M372R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	A395D	0	.	.	1183	1185	GCC	1499	1501	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A395D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	C403Y	0	.	.	1207	1209	TGT	1523	1525	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:C403Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1058	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2115	0.0	1	SNP	p	F480S	0	.	.	1438	1440	TTC	1754	1756	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:F480S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	T20P	0	.	.	58	60	ACT	464	466	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:T20P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	E40G	0	.	.	118	120	GAG	524	526	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	E40Q	0	.	.	118	120	GAG	524	526	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40Q:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	I43A	0	.	.	127	129	ATC	533	535	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	I43T	0	.	.	127	129	ATC	533	535	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43T:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	I43S	0	.	.	127	129	ATC	533	535	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43S:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	R49P	0	.	.	145	147	CGG	551	553	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	R49W	0	.	.	145	147	CGG	551	553	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	L56V	0	.	.	166	168	CTG	572	574	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:L56V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	R91W	0	.	.	271	273	CGG	677	679	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R91W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	S150G	0	.	.	448	450	AGC	854	856	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	S150C	0	.	.	448	450	AGC	854	856	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150C:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	E153G	0	.	.	457	459	GAG	863	865	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	E153A	0	.	.	457	459	GAG	863	865	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	732	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2193	0.0	1	SNP	p	A420V	0	.	.	1258	1260	GCG	1664	1666	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:A420V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	G30R	0	.	.	88	90	GGT	506	508	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G30R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	G37V	0	.	.	109	111	GGA	527	529	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G37V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	W45C	0	.	.	133	135	TGG	551	553	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	W45S	0	.	.	133	135	TGG	551	553	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	R47Q	0	.	.	139	141	CGG	557	559	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:R47Q:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	H48Y	0	.	.	142	144	CAT	560	562	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:H48Y:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	L49F	0	.	.	145	147	CTA	563	565	CTA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L49F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	I55S	0	.	.	163	165	ATC	581	583	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:I55S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	D67H	0	.	.	199	201	GAT	617	619	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:D67H:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	S70R	0	.	.	208	210	AGC	626	628	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:S70R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	G71V	0	.	.	211	213	GGA	629	631	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G71V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	P75S	0	.	.	223	225	CCG	641	643	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P75S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	L79F	0	.	.	235	237	TTG	653	655	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	L79S	0	.	.	235	237	TTG	653	655	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	P84C	0	.	.	250	252	CCG	668	670	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	P84L	0	.	.	250	252	CCG	668	670	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84L:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	E92A	0	.	.	274	276	GAA	692	694	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:E92A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	G117E	0	.	.	349	351	GGG	767	769	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G117E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	V124G	0	.	.	370	372	GTG	788	790	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V124G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAA	797	799	CAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:Q127P:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	A134E	0	.	.	400	402	GCG	818	820	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A134E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	A138E	0	.	.	412	414	GCG	830	832	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A138E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	833	835	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V139A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	W148R	0	.	.	442	444	TGG	860	862	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W148R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	G164C	0	.	.	490	492	GGC	908	910	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G164C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	A183T	0	.	.	547	549	GCG	965	967	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	A183E	0	.	.	547	549	GCG	965	967	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	V188M	0	.	.	562	564	GTG	980	982	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188M:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	V188G	0	.	.	562	564	GTG	980	982	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	550	gidB	675	675	99.85	gidB.l6.c30.ctg.1	1566	0.0	1	SNP	p	A200E	0	.	.	598	600	GCG	1016	1018	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A200E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	0	.	p	.	0	E21Q	NONSYN	61	63	GAG	630	632	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	0	.	p	.	0	S95T	NONSYN	283	285	AGC	852	854	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	0	.	p	.	0	G668D	NONSYN	2002	2004	GGC	2571	2573	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	A74S	0	.	.	220	222	GCC	789	791	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A74S:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	T80A	0	.	.	238	240	ACC	807	809	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:T80A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	G88A	0	.	.	262	264	GGC	831	833	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	G88C	0	.	.	262	264	GGC	831	833	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88C:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	D89V	0	.	.	265	267	GAC	834	836	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	D89G	0	.	.	265	267	GAC	834	836	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	D89N	0	.	.	265	267	GAC	834	836	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	A90G	0	.	.	268	270	GCG	837	839	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	A90V	0	.	.	268	270	GCG	837	839	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	S91P	0	.	.	271	273	TCG	840	842	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:S91P:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	D94V	0	.	.	280	282	GAC	849	851	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	D94T	0	.	.	280	282	GAC	849	851	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94T:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	D94Y	0	.	.	280	282	GAC	849	851	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94Y:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	D94N	0	.	.	280	282	GAC	849	851	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	D94A	0	.	.	280	282	GAC	849	851	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	D94G	0	.	.	280	282	GAC	849	851	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1630	gyrA_1	2517	2517	99.88	gyrA_1.l15.c4.ctg.1	3478	0.0	1	SNP	p	P102H	0	.	.	304	306	CCC	873	875	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:P102H:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1658	gyrB_6	2145	2145	99.95	gyrB_6.l6.c30.ctg.1	3027	0.0	1	SNP	p	V340L	0	.	.	1018	1020	GTG	1485	1487	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:V340L:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1658	gyrB_6	2145	2145	99.95	gyrB_6.l6.c30.ctg.1	3027	0.0	1	SNP	p	D500H	0	.	.	1498	1500	GAC	1965	1967	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:D500H:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1658	gyrB_6	2145	2145	99.95	gyrB_6.l6.c30.ctg.1	3027	0.0	1	SNP	p	N538D	0	.	.	1612	1614	AAC	2079	2081	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1658	gyrB_6	2145	2145	99.95	gyrB_6.l6.c30.ctg.1	3027	0.0	1	SNP	p	N538K	0	.	.	1612	1614	AAC	2079	2081	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538K:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1658	gyrB_6	2145	2145	99.95	gyrB_6.l6.c30.ctg.1	3027	0.0	1	SNP	p	T539P	0	.	.	1615	1617	ACC	2082	2084	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539P:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1658	gyrB_6	2145	2145	99.95	gyrB_6.l6.c30.ctg.1	3027	0.0	1	SNP	p	T539N	0	.	.	1615	1617	ACC	2082	2084	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539N:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1658	gyrB_6	2145	2145	99.95	gyrB_6.l6.c30.ctg.1	3027	0.0	1	SNP	p	E540D	0	.	.	1618	1620	GAA	2085	2087	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1658	gyrB_6	2145	2145	99.95	gyrB_6.l6.c30.ctg.1	3027	0.0	1	SNP	p	E540V	0	.	.	1618	1620	GAA	2085	2087	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540V:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	462	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1643	0.0	1	SNP	p	I16T	0	.	.	46	48	ATC	551	553	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I16T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	462	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1643	0.0	1	SNP	p	I21T	0	.	.	61	63	ATC	566	568	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	462	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1643	0.0	1	SNP	p	I21V	0	.	.	61	63	ATC	566	568	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21V:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	462	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1643	0.0	1	SNP	p	I47T	0	.	.	139	141	ATT	644	646	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I47T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	462	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1643	0.0	1	SNP	p	V78A	0	.	.	232	234	GTG	737	739	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:V78A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	462	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1643	0.0	1	SNP	p	S94A	0	.	.	280	282	TCG	785	787	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:S94A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	462	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1643	0.0	1	SNP	p	I95P	0	.	.	283	285	ATT	788	790	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I95P:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	462	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1643	0.0	1	SNP	p	G141E	0	.	.	421	423	GGA	926	928	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:G141E:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	462	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1643	0.0	1	SNP	p	I194T	0	.	.	580	582	ATC	1085	1087	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I194T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1168	iniA	1923	1923	100.0	iniA.l6.c17.ctg.1	2700	0.0	1	SNP	p	P3A	0	.	.	7	9	CCC	367	369	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:P3A:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1168	iniA	1923	1923	100.0	iniA.l6.c17.ctg.1	2700	0.0	1	SNP	p	G308R	0	.	.	922	924	GGG	1282	1284	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:G308R:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1168	iniA	1923	1923	100.0	iniA.l6.c17.ctg.1	2700	0.0	1	SNP	p	S501W	0	.	.	1501	1503	TCG	1861	1863	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:S501W:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1168	iniA	1923	1923	100.0	iniA.l6.c17.ctg.1	2700	0.0	1	SNP	p	R537H	0	.	.	1609	1611	CGC	1969	1971	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:R537H:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	27	568	iniB	1440	1440	100.0	iniB.l15.c4.ctg.1	2423	0.0	1	SNP	p	A47T	0	.	.	139	141	GCC	620	622	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniB.3004135.AL123456.3.409361_410801.5509:1:1:A47T:.:b'Point mutations in M. tuberculosis iniB shown to confer resistance to ethambutol.'	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	898	iniC	1482	1482	100.0	iniC.l15.c4.ctg.1	2358	0.0	1	SNP	p	W83G	0	.	.	247	249	TGG	766	768	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:W83G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	898	iniC	1482	1482	100.0	iniC.l15.c4.ctg.1	2358	0.0	1	SNP	p	P248A	0	.	.	742	744	CCG	1261	1263	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:P248A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	773	574	kasA	1251	1109	100.0	kasA.l15.c30.ctg.1	1451	0.0	1	SNP	p	D66N	0	.	.	196	198	GAT	538	540	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:D66N:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	773	574	kasA	1251	1109	100.0	kasA.l15.c30.ctg.1	1451	0.0	1	SNP	p	R121K	0	.	.	361	363	AGG	703	705	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:R121K:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	773	574	kasA	1251	1109	100.0	kasA.l15.c30.ctg.1	1451	0.0	1	SNP	p	G269S	0	.	.	805	807	GGT	1147	1149	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G269S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	773	574	kasA	1251	1109	100.0	kasA.l15.c30.ctg.1	1451	0.0	1	SNP	p	G312S	0	.	.	934	936	GGC	1276	1278	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G312S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	773	574	kasA	1251	286	100.0	kasA.l15.c30.ctg.2	442	0.0	1	SNP	p	G387D	0	.	.	1159	1161	GGC	194	196	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G387D:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	773	574	kasA	1251	286	100.0	kasA.l15.c30.ctg.2	442	0.0	1	SNP	p	F413L	0	.	.	1237	1239	TTC	272	274	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:F413L:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	773	574	kasA	1251	224	97.85	kasA.l15.c30.ctg.3	378	0.0	0	.	p	.	0	T315S	NONSYN	943	945	ACG	81	83	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	773	574	kasA	1251	224	97.85	kasA.l15.c30.ctg.3	378	0.0	0	.	p	.	0	D319V	NONSYN	955	957	GAC	93	95	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	773	574	kasA	1251	224	97.85	kasA.l15.c30.ctg.3	378	0.0	1	SNP	p	G312S	0	.	.	934	936	GGC	72	74	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G312S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	0	.	p	.	0	R463L	NONSYN	1387	1389	CGG	1854	1856	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	G33V	0	.	.	97	99	GGC	564	566	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G33V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	W91R	0	.	.	271	273	TGG	738	740	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:W91R:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	A110V	0	.	.	328	330	GCC	795	797	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A110V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	G111S	0	.	.	331	333	GGC	798	800	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G111S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	G125S	0	.	.	373	375	GGC	840	842	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G125S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	M126I	0	.	.	376	378	ATG	843	845	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:M126I:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAG	846	848	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q127P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	D142G	0	.	.	424	426	GAC	891	893	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:D142G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	L147P	0	.	.	439	441	CTG	906	908	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:L147P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	A264V	0	.	.	790	792	GCG	1257	1259	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A264V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	A312P	0	.	.	934	936	GCG	1401	1403	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A312P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	S315T	0	.	.	943	945	AGC	1410	1412	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315T:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	S315G	0	.	.	943	945	AGC	1410	1412	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	S315N	0	.	.	943	945	AGC	1410	1412	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315N:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	H417Q	0	.	.	1249	1251	CAC	1716	1718	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:H417Q:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	Q461P	0	.	.	1381	1383	CAG	1848	1850	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q461P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	G490S	0	.	.	1468	1470	GGC	1935	1937	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G490S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	N508D	0	.	.	1522	1524	AAC	1989	1991	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N508D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	E607A	0	.	.	1819	1821	GAG	2286	2288	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:E607A:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1342	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	3126	0.0	1	SNP	p	N660D	0	.	.	1978	1980	AAC	2445	2447	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N660D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
mfpA.3003035.AL123456.1.3773015_3773567.4588	mfpA.3003035.AL123456.1.3773015_3773567.4588	1	0	27	430	mfpA	552	552	100.0	mfpA.l15.c4.ctg.1	1498	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mfpA;b'mfpA is a qnr homolog and a pentapeptide repeat protein that confers resistance to fluoroquinolones in Mycolicibacterium smegmatis.'
mshA.3005108.NC_000962.3.575347_576790.6150	mshA.3005108.NC_000962.3.575347_576790.6150	1	1	27	756	mshA_1	1443	1443	100.0	mshA_1.l6.c4.ctg.1	2231	0.0	1	SNP	p	F355S	0	.	.	1063	1065	TTC	1480	1482	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	mshA.3005108.NC_000962.3.575347_576790.6150:1:1:F355S:.:b'Mutations in Mycobacterium tuberculosis mshA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis mshA mutations conferring resistance to prothionamide
murA.3003784.HE608151.1.1472985_1474242.3555	murA.3003784.HE608151.1.1472985_1474242.3555	1	1	27	926	murA_4	1257	1257	100.0	murA_4.l15.c4.ctg.1	1902	0.0	1	SNP	p	C117D	1	.	.	349	351	GAC	679	681	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	murA.3003784.HE608151.1.1472985_1474242.3555:1:1:C117D:.:b'Mycobacterium tuberculosis murA confers intrinsic resistance to fosfomycin. The presence of an aspartic acid residue in place of the critical cysteine at position 117 that enables fosfomycin binding is believed to be responsible for this intrinsic resistance.'	Mycobacterium tuberculosis intrinsic murA conferring resistance to fosfomycin
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	M1S	0	.	.	1	3	ATG	356	358	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M1S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	A3E	0	.	.	7	9	GCG	362	364	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A3E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	L4W	0	.	.	10	12	TTG	365	367	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L4W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	I5S	0	.	.	13	15	ATC	368	370	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I5S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	V7F	0	.	.	19	21	GTC	374	376	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	V7D	0	.	.	19	21	GTC	374	376	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	V7G	0	.	.	19	21	GTC	374	376	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	D8Y	0	.	.	22	24	GAC	377	379	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D8Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	V9A	0	.	.	25	27	GTG	380	382	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	V9G	0	.	.	25	27	GTG	380	382	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	Q10K	0	.	.	28	30	CAG	383	385	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	Q10R	0	.	.	28	30	CAG	383	385	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	Q10P	0	.	.	28	30	CAG	383	385	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	D12A	0	.	.	34	36	GAC	389	391	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	D12E	0	.	.	34	36	GAC	389	391	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	D12N	0	.	.	34	36	GAC	389	391	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	C14R	0	.	.	40	42	TGC	395	397	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	C14Y	0	.	.	40	42	TGC	395	397	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	G17S	0	.	.	49	51	GGC	404	406	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	G17D	0	.	.	49	51	GGC	404	406	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	L19P	0	.	.	55	57	CTG	410	412	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L19P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	G23V	0	.	.	67	69	GGT	422	424	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G23V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	A26G	0	.	.	76	78	GCG	431	433	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A26G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	L27P	0	.	.	79	81	CTG	434	436	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L27P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	Y34S	0	.	.	100	102	TAC	455	457	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y34S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	Y41H	0	.	.	121	123	TAC	476	478	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y41H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	V45G	0	.	.	133	135	GTG	488	490	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V45G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	A46V	0	.	.	136	138	GCA	491	493	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	A46E	0	.	.	136	138	GCA	491	493	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	T47S	0	.	.	139	141	ACC	494	496	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	T47A	0	.	.	139	141	ACC	494	496	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	T47P	0	.	.	139	141	ACC	494	496	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	D49V	0	.	.	145	147	GAC	500	502	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	D49A	0	.	.	145	147	GAC	500	502	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	H51Y	0	.	.	151	153	CAC	506	508	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	H51Q	0	.	.	151	153	CAC	506	508	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	D53A	0	.	.	157	159	GAC	512	514	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D53A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	P54L	0	.	.	160	162	CCG	515	517	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	P54T	0	.	.	160	162	CCG	515	517	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	H57D	0	.	.	169	171	CAC	524	526	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	H57Q	0	.	.	169	171	CAC	524	526	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	F58L	0	.	.	172	174	TTC	527	529	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F58L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	P62H	0	.	.	184	186	CCG	539	541	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P62H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	S66P	0	.	.	196	198	TCG	551	553	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S66P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	S67P	0	.	.	199	201	TCG	554	556	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S67P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	W68L	0	.	.	202	204	TGG	557	559	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	W68S	0	.	.	202	204	TGG	557	559	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	W68G	0	.	.	202	204	TGG	557	559	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	W68R	0	.	.	202	204	TGG	557	559	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	W68C	0	.	.	202	204	TGG	557	559	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	P69R	0	.	.	205	207	CCA	560	562	CCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P69R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	H71E	0	.	.	211	213	CAT	566	568	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H71E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	C72R	0	.	.	214	216	TGC	569	571	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	C72W	0	.	.	214	216	TGC	569	571	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	T76P	0	.	.	226	228	ACT	581	583	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	T76I	0	.	.	226	228	ACT	581	583	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76I:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	G78D	0	.	.	232	234	GGC	587	589	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G78D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	H82R	0	.	.	244	246	CAT	599	601	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H82R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	L85R	0	.	.	253	255	CTG	608	610	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	L85P	0	.	.	253	255	CTG	608	610	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	I90S	0	.	.	268	270	ATC	623	625	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I90S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	F94P	0	.	.	280	282	TTC	635	637	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F94P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	K96N	0	.	.	286	288	AAG	641	643	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	K96Q	0	.	.	286	288	AAG	641	643	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	K96M	0	.	.	286	288	AAG	641	643	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	K96E	0	.	.	286	288	AAG	641	643	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	G97S	0	.	.	289	291	GGT	644	646	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G97S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	T100P	0	.	.	298	300	ACC	653	655	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T100P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	A102T	0	.	.	304	306	GCG	659	661	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	A102V	0	.	.	304	306	GCG	659	661	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	Y103S	0	.	.	307	309	TAC	662	664	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	Y103H	0	.	.	307	309	TAC	662	664	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	S104C	0	.	.	310	312	AGC	665	667	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S104C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	L116R	0	.	.	346	348	CTG	701	703	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L116R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	N118T	0	.	.	352	354	AAT	707	709	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:N118T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	W119R	0	.	.	355	357	TGG	710	712	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W119R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	R121P	0	.	.	361	363	CGG	716	718	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R121P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	V125D	0	.	.	373	375	GTC	728	730	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V125D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	G132S	0	.	.	394	396	GGT	749	751	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G132S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	I133T	0	.	.	397	399	ATT	752	754	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I133T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	A134V	0	.	.	400	402	GCC	755	757	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A134V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	T135P	0	.	.	403	405	ACC	758	760	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T135P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	D136N	0	.	.	406	408	GAT	761	763	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	D136Y	0	.	.	406	408	GAT	761	763	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	D136H	0	.	.	406	408	GAT	761	763	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	H137P	0	.	.	409	411	CAT	764	766	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	H137R	0	.	.	409	411	CAT	764	766	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	C138Y	0	.	.	412	414	TGT	767	769	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	C138S	0	.	.	412	414	TGT	767	769	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	C138W	0	.	.	412	414	TGT	767	769	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	770	772	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	V139L	0	.	.	415	417	GTG	770	772	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	V139M	0	.	.	415	417	GTG	770	772	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	R140G	0	.	.	418	420	CGC	773	775	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R140G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	Q141P	0	.	.	421	423	CAG	776	778	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q141P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	T142K	0	.	.	424	426	ACG	779	781	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	T142M	0	.	.	424	426	ACG	779	781	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	A146T	0	.	.	436	438	GCG	791	793	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A146T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	R154G	0	.	.	460	462	AGG	815	817	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R154G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	V155G	0	.	.	463	465	GTG	818	820	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V155G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	V157G	0	.	.	469	471	GTG	824	826	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V157G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	L159R	0	.	.	475	477	CTG	830	832	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L159R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	T160P	0	.	.	478	480	ACA	833	835	ACA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T160P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	A161G	0	.	.	481	483	GCG	836	838	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	A161P	0	.	.	481	483	GCG	836	838	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	S164P	0	.	.	490	492	TCG	845	847	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S164P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	T168N	0	.	.	502	504	ACC	857	859	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T168N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	A171T	0	.	.	511	513	GCG	866	868	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	A171P	0	.	.	511	513	GCG	866	868	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	A171V	0	.	.	511	513	GCG	866	868	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	L172A	0	.	.	514	516	CTG	869	871	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	L172P	0	.	.	514	516	CTG	869	871	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	E174G	0	.	.	520	522	GAG	875	877	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:E174G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	M175V	0	.	.	523	525	ATG	878	880	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M175V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	V180F	0	.	.	538	540	GTC	893	895	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V180F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	442	pncA	561	561	99.82	pncA.l15.c17.ctg.1	1538	0.0	1	SNP	p	L182S	0	.	.	544	546	TTG	899	901	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L182S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
ribD.3004184.AL123456.3.2986838_2987615.5511	ribD.3004184.AL123456.3.2986838_2987615.5511	1	1	27	486	ribD	777	777	100.0	ribD.l6.c4.ctg.1	1773	0.0	1	SNP	p	G8R	0	.	.	22	24	GGA	553	555	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ribD.3004184.AL123456.3.2986838_2987615.5511:1:1:G8R:.:b'ribD is a Mycobacterium tuberculosis riboflavin biosynthesis enzyme. Point mutations in ribD cause enzyme overexpression, which allows the C-terminal reductase domain to act as an alternative dihydrofolate reductase. Thus, mutations in ribD confer resistance to DHFR inhibitors such as para-aminosalicylic acid.'	Mycobacterium tuberculosis ribD with mutation conferring resistance to para-aminosalicylic acid
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2102	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	4176	0.0	1	SNP	p	V146F	0	.	.	436	438	GTG	840	842	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:V146F:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2102	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	4176	0.0	1	SNP	p	S450L	0	.	.	1348	1350	TCG	1752	1754	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:S450L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2102	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	4176	0.0	1	SNP	p	F505L	0	.	.	1513	1515	TTC	1917	1919	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:F505L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2102	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	4176	0.0	1	SNP	p	T508P	0	.	.	1522	1524	ACG	1926	1928	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508P:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2102	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	4176	0.0	1	SNP	p	T508H	0	.	.	1522	1524	ACG	1926	1928	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508H:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2102	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	4176	0.0	1	SNP	p	T508N	0	.	.	1522	1524	ACG	1926	1928	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508N:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2102	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	4176	0.0	1	SNP	p	T508S	0	.	.	1522	1524	ACG	1926	1928	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508S:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2102	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	4176	0.0	1	SNP	p	T508A	0	.	.	1522	1524	ACG	1926	1928	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508A:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2102	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	4176	0.0	1	SNP	p	L511R	1	.	.	1531	1533	CGC	1935	1937	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:L511R:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2102	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	4176	0.0	1	SNP	p	D516G	1	.	.	1546	1548	GGC	1950	1952	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:D516G:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2102	rpoB_1	3519	3519	99.94	rpoB_1.l6.c4.ctg.1	4176	0.0	1	SNP	p	H526T	1	.	.	1576	1578	ACC	1980	1982	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:H526T:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	886	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2102	0.0	1	SNP	p	D123A	0	.	.	367	369	GAC	634	636	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D123A:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	886	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2102	0.0	1	SNP	p	S324F	0	.	.	970	972	TCC	1237	1239	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:S324F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	886	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2102	0.0	1	SNP	p	E325K	0	.	.	973	975	GAG	1240	1242	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:E325K:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	886	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2102	0.0	1	SNP	p	G341R	0	.	.	1021	1023	GGC	1288	1290	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:G341R:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	886	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2102	0.0	1	SNP	p	D342N	0	.	.	1024	1026	GAC	1291	1293	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D342N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	886	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2102	0.0	1	SNP	p	D343N	0	.	.	1027	1029	GAC	1294	1296	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D343N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	886	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2102	0.0	1	SNP	p	A344P	0	.	.	1030	1032	GCG	1297	1299	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:A344P:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	886	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2102	0.0	1	SNP	p	I351F	0	.	.	1051	1053	ATC	1318	1320	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:I351F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	406	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	1566	0.0	1	SNP	p	T40I	0	.	.	118	120	ACC	706	708	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:T40I:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	406	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	1566	0.0	1	SNP	p	K43R	0	.	.	127	129	AAG	715	717	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K43R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	406	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	1566	0.0	1	SNP	p	K88Q	0	.	.	262	264	AAG	850	852	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88Q:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	406	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	1566	0.0	1	SNP	p	K88R	0	.	.	262	264	AAG	850	852	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	T22A	0	.	.	64	66	ACC	555	557	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T22A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	Y36C	0	.	.	106	108	TAT	597	599	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:Y36C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	H75N	0	.	.	223	225	CAC	714	716	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H75N:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	V77F	0	.	.	229	231	GTC	720	722	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:V77F:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	W83C	0	.	.	247	249	TGG	738	740	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W83C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	G91R	0	.	.	271	273	GGG	762	764	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:G91R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	W101R	0	.	.	301	303	TGG	792	794	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W101R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	S105P	0	.	.	313	315	TCC	804	806	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:S105P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	R126Q	0	.	.	376	378	CGG	867	869	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R126Q:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	F152V	0	.	.	454	456	TTC	945	947	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:F152V:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	C161T	0	.	.	481	483	TGT	972	974	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:C161T:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	T202A	0	.	.	604	606	ACC	1095	1097	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T202A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	H207R	0	.	.	619	621	CAC	1110	1112	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H207R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	P224L	0	.	.	670	672	CCG	1161	1163	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:P224L:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	580	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1763	0.0	1	SNP	p	R235P	0	.	.	703	705	CGG	1194	1196	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R235P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	384	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1488	0.0	1	SNP	p	R14W	0	.	.	40	42	CGG	363	365	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:R14W:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	384	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1488	0.0	1	SNP	p	A67E	0	.	.	199	201	GCG	522	524	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A67E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	384	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1488	0.0	1	SNP	p	K69E	0	.	.	205	207	AAA	528	530	AAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:K69E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	384	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1488	0.0	1	SNP	p	A91E	0	.	.	271	273	GCA	594	596	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A91E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	384	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1488	0.0	1	SNP	p	L118P	0	.	.	352	354	CTG	675	677	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L118P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	384	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1488	0.0	1	SNP	p	V128E	0	.	.	382	384	GTG	705	707	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:V128E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	384	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1488	0.0	1	SNP	p	L150P	0	.	.	448	450	CTG	771	773	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L150P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	384	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1488	0.0	1	SNP	p	P183L	0	.	.	547	549	CCG	870	872	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:P183L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	384	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1488	0.0	1	SNP	p	F185L	0	.	.	553	555	TTT	876	878	TTT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:F185L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	384	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1488	0.0	1	SNP	p	N236K	0	.	.	706	708	AAT	1029	1031	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:N236K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	384	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1488	0.0	1	SNP	p	E238K	0	.	.	712	714	GAG	1035	1037	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:E238K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
